# The direct transfer approach for transcellular drug delivery

**Authors:** Yi-Fan Wang, Ze-Fan Shen, Fang-yue Xiang, Heng Wang, Pu Zhang, Qi Zhang

PMC · DOI: 10.1080/10717544.2023.2288799 · Drug Delivery · 2023-11-30

## TL;DR

This paper reviews a new drug delivery method called direct transfer, which uses cell-to-cell contact to quickly and deeply deliver drugs into tissues.

## Contribution

The paper introduces and categorizes three distinct modalities of direct transfer for transcellular drug delivery.

## Key findings

- Direct transfer enables rapid and deep drug penetration into tissues via cell-cell contact.
- Three modalities of direct transfer are identified: membrane contact, gap junctions, and tunneling nanotubes.
- Each modality has unique structures and effectiveness for drug delivery.

## Abstract

A promising paradigm for drug administration that has garnered increasing attention in recent years is the direct transfer (DT) of nanoparticles for transcellular drug delivery. DT requires direct cell-cell contact and facilitates unidirectional and bidirectional matter exchange between neighboring cells. Consequently, DT enables fast and deep penetration of drugs into the targeted tissues. This comprehensive review discusses the direct transfer concept, which can be delineated into the following three distinct modalities: membrane contact-direct transfer, gap junction-mediated direct transfer (GJ-DT), and tunneling nanotubes-mediated direct transfer (TNTs-DT). Further, the intercellular structures for each modality of direct transfer and their respective merits and demerits are summarized. The review also discusses the recent progress on the drugs or drug delivery systems that could activate DT.

## Full-text entities

- **Genes:** MIR183 (microRNA 183) [NCBI Gene 406959] {aka MIRN183, miR-183, miRNA183}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, SNCA (synuclein alpha) [NCBI Gene 6622] {aka NACP, PARK1, PARK4, PD1}, MIR96 (microRNA 96) [NCBI Gene 407053] {aka DFNA50, MIRN96, hsa-mir-96, miR-96, miRNA96}, GJA1 (gap junction protein alpha 1) [NCBI Gene 2697] {aka AVSD3, CMDR, CX43, EKVP, EKVP3, GJAL}, GJB3 (gap junction protein beta 3) [NCBI Gene 2707] {aka CX31, DFNA2, DFNA2B, EKV, EKVP1}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, GJB2 (gap junction protein beta 2) [NCBI Gene 2706] {aka BAPS, CX26, DFNA3, DFNA3A, DFNB1, DFNB1A}, GJB6 (gap junction protein beta 6) [NCBI Gene 10804] {aka CX30, DFNA3, DFNA3B, DFNB1B, ECTD2, ED2}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}
- **Diseases:** ovarian cancer (MESH:D010051), lung cancer (MESH:D008175), C6 glioma (MESH:C567307), TNT (MESH:D020425), DT (MESH:D051556), neurodegenerative disease (MESH:D019636), metastasis (MESH:D009362), infection (MESH:D007239), Cancer (MESH:D009369)
- **Chemicals:** DoxHCL (-), lipid (MESH:D008055), polyQ (MESH:C097188), latrunculin B (MESH:C037068), arginine (MESH:D001120), FITC-dextran (MESH:C015219), dextran (MESH:D003911), gemcitabine (MESH:D000093542), biopolymer (MESH:D001704), dynasore (MESH:C511794), cytochalasin D (MESH:D015638), PBS (MESH:D007854), heparin (MESH:D006493), luciferin (MESH:D000090562), ammonium chloride (MESH:D000643), Silica (MESH:D012822), CM-DiI. (MESH:C101089), CPPs (MESH:D057846), glucose (MESH:D005947), polyethylene glycol (MESH:D011092), cGAMP (MESH:C584311), MDC (MESH:C008542), GCV (MESH:D015774), chloroquine (MESH:D002738), lipid bilayer (MESH:D008051), doxorubicin (MESH:D004317), peptides (MESH:D010455)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Human immunodeficiency virus 1 (no rank) [taxon 11676]
- **Cell lines:** C6 glioma — Rattus norvegicus (Rat), Rat malignant glioma, Cancer cell line (CVCL_3581), 293Cx43 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_4574), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), RAW macrophage — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_F681), SKOV3 tumor — Homo sapiens (Human), Ovarian serous cystadenocarcinoma, Cancer cell line (CVCL_0532), Raji — Homo sapiens (Human), EBV-related Burkitt lymphoma, Cancer cell line (CVCL_0511), U87 — Homo sapiens (Human), Glioblastoma, Cancer cell line (CVCL_0022), HEK-293Cx43 — Homo sapiens (Human), Transformed cell line (CVCL_0045), bEnd.3 — Mus musculus (Mouse), Transformed cell line (CVCL_0170), SH-SY5Y — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_0019), RAW Macrophages — Labeo rohita (Indian major carp), Spontaneously immortalized cell line (CVCL_A8VR), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), A431-R — Homo sapiens (Human), Skin squamous cell carcinoma, Cancer cell line (CVCL_0037)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10987047/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10987047/full.md

## References

94 references — full list in the complete paper: https://tomesphere.com/paper/PMC10987047/full.md

---
Source: https://tomesphere.com/paper/PMC10987047